Navigation Links
Progen to Present Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
Date:11/2/2007

BRISBANE, Australia, Nov. 2 /PRNewswire-FirstCall/ -- Progen Pharmaceuticals Limited (ASX: PGL; Nasdaq: PGLA) today announced that Dr. James Garner, Progen's Vice President of Clinical and Medical Affairs will present a poster entitled "The Interactive Effect of Prognostic Factors and PI-88 Use on the Delay of HCC Recurrence Following Curative Partial Hepatic Resection" at the 58th Annual Meeting of the American Association for the Study of Liver Diseases in Boston, USA(1) on Saturday, 3 November 2007.

The poster presentation will be made available on Progen's website http://www.progen-pharma.com from approximately 9am (Brisbane time) Saturday 3 November 2007.

(1) Each year, the American Association for the Study of Liver Diseases brings together over 6,000 hepatologists and hepatology health professionals from around the world for its annual meeting to meet and exchange the latest liver disease research, and discuss treatment outcomes.

About PI-88: PI-88 is one of a new class of multi-targeted cytostatic cancer therapeutics. It is a novel anti-cancer compound with a first-in-class mechanism as a heparan sulfate mimetic. Its anti-tumor activity is based on inhibition of two biological processes -- angiogenesis (the growth of new blood vessels) and metastasis (the spread of cancer to other sites) -- critical to the growth and progression of cancer. In a phase 2 trial in post- resection liver cancer, 160mg of PI-88 demonstrated a 25% improvement in the primary endpoint of disease-free rate at 48 weeks and 78% improvement in secondary endpoint of disease-free survival. These results, combined with positive feedback from the FDA, provide Progen with confidence in the potential of PI-88 for this indication and we are therefore aggressively pursuing its development towards registration and commercialization.

About Progen: Progen Pharmaceuticals Limited is an Australia-based globally fo
'/>"/>

SOURCE Progen Pharmaceuticals Limited
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. The secrets for a healthy progeny: Mother’s diet during pregnancy
2. Lizard Mothers Dress Their Progeny to Ensure Success in Later Life
3. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
4. Researchers Present Ways To Reduce The Risk Of Dementia
5. Researchers Present Data Regarding The Efficiency Of Herbs
6. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
7. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
8. Drug Reactions First Present Themselves In The Mouth
9. Reminiscing Into The Past Makes You Dissatisfied With The Present
10. Living In The Past Indicates Dissatisfaction With Present
11. Movies Represent Coma In A Wrong Way
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... July 06, 2015 , ... “ TapGlance ” was ... the latest and coolest applications on the market for iOS, Android, and Windows. Joe ... with viewers how this interior design app helps users visualize what rooms will look ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... Spa industries, announces the return of its complimentary educational webinar series ... medical business leaders creates success for their clients through targeted marketing, sales, digital ...
(Date:7/6/2015)... ... July 06, 2015 , ... Understanding the new ... ADVOCATE is leading the transition. ADVOCATE, the only 100% radiology, revenue cycle management ... Tips for ICD-10. The ten tips are timely and relevant guidelines to help ...
(Date:7/6/2015)... , ... July 06, 2015 , ... Health care systems ... ability of the medical field to access and use this “Big Data” to improve ... President and Chief Executive Officer of the Mount Sinai Health System in New York ...
(Date:7/6/2015)... ... July 06, 2015 , ... The School ... funds to support a three-year effort to reduce rates of diabetes and cardiovascular ... in partnership with the Morehouse School of Medicine’s Prevention Research Center and the ...
Breaking Medicine News(10 mins):Health News:Create a Space with TapGlance, a Revolutionary Interior Design Application 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 3Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 3Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 4Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 5Health News:Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities 2
... new mothers dying each year , , THURSDAY, Jan. 15 (HealthDay ... world,s poorest countries is 300 times more likely to die ... nations, a UNICEF annual report released Thursday shows. , The ... that infants born in developing nations have a 14-fold higher ...
... solutions to the budgeting, forecasting, and operational planning challenges presented ... trial scenarios accounting for shifting resource allocations, timelines, treatment arms, ... ... January 15, 2009 -- ClearTrial ( www.cleartrial.com ), a leading ...
... to Bridge GapsSAN FRANCISCO, Jan. 15 Findings from ... that the shortage among allied health workers is putting ... shortage is causing a number of problems such as ... to serve more patients."Community clinics represent the front lines ...
... BROOK, Ill. January 15, 2009 The ... endoscopy units as part of its new program specifically ... where it is practiced in the United States. The ... follow the ASGE guidelines on privileging, quality assurance, endoscopy ...
... a leading,innovator of physiological monitoring solutions, has been ... 2009 award for the Onyx(R) II, Model 9560,fingertip ... oximeter,the innovative device combines Bluetooth(R) wireless technology with ... accurately,monitor vital signs. , ...
... CONTINUES AS CHAIRMANNEW YORK, Jan. 15 The National ... Columbia University announced today that Join Together(TM) will ... will become the President and Chief Executive Officer of ... Jr., the former U.S. Secretary of Health, Education, and ...
Cached Medicine News:Health News:Mothers, Newborns at High Risk in Developing World 2Health News:ClearTrial to Provide Guidelines for Accurately Forecasting and Budgeting Adaptive Clinical Trials at CBI Conference 2Health News:Allied Health Worker Shortage Strains Community Clinics 2Health News:Allied Health Worker Shortage Strains Community Clinics 3Health News:ASGE recognizes 56 endoscopy units for quality and safety through Endoscopy Unit Recognition Program 2Health News:ASGE recognizes 56 endoscopy units for quality and safety through Endoscopy Unit Recognition Program 3Health News:Nonin Medical's Onyx(R) II, Model 9560 Receives Bluetooth SIG's Best of CES 2009 Award 2Health News:Join Together(tm) Merges Into CASA* 2Health News:Join Together(tm) Merges Into CASA* 3
(Date:7/6/2015)... DUBLIN , June 29, 2015 ... the addition of the "Pharmaceutical Packaging Market in ... The pharmaceutical packaging market in North ... 5.31% over the period 2014-2019. International ... bodies on drug manufacturers, which in turn fuels adoption ...
(Date:7/6/2015)... July 6, 2015 E-QURE Corp (OTCQB: EQUR), ... live at VirtualInvestorConferences.com on July 9, 2015. ... http://tinyurl.com/e-qure-presentation This will be a ... ask the company questions in real-time - both in ... trade booth." If attendees are not able to join ...
(Date:7/6/2015)... ATLANTA , July 6, 2015 Celtaxsys, ... anti-inflammatory therapeutics, including those with rare and orphan inflammatory ... from the U.S. Food and Drug Administration (FDA) to ... drug candidate, acebilustat (CTX-4430), in adult CF patients in ... in Europe will be filed ...
Breaking Medicine Technology:North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 2North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 3E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3
MultiWash Advantage is a versatile microplate washer engineered for reliability. It is designed for lab environments to help streamline their daily processes....
Synchron Hemoglobin A1c (HbA1c) utilizes two unique cartridges, Hb and A1c, to determine HbA1c concentration as a percentage of total hemoglobin....
... Monoclonal antibody method for HbA1c provides outstanding ... 99% agreement with the HPLC method(1) , ... a CV of 2.6%* means your results ... (NGSP) certified method, as recommended by the ...
The sole coagulation analyzer in the world that uses a unique dry reagent card....
Medicine Products: